Chains now handle 54.4% of prescriptions; mail order flat at 6.6%
The “Use of Medicines in the United States” report from the IMS Institute for Healthcare Informatics (see item below) provides a detailed look at where prescriptions are filled, and money spent, by consumers. The overall trends vary only slightly from the year before, but show a continuation of prescriptions being filled at chain drugstores over independents, and flattening of spending and prescription-filling at mail order providers.
The overall market was worth $307.4B in 2010. Of that $108.1B, or 35.2%, was spent at chain drugstores, up a hair from 35.1% in 2009. Spending at independent drugstores was $37.9B, 12.3% of the total, but down from 2009’s 12.4%. Mail service garnered $52.6B of spending, or 17.1%, the same percentage it saw in 2009. There had been a slow growth trend in mail service going back several years, but that appears to be cresting. (Pharmaceutical Commerce Editorial Board member Adam Fein points out that retail revenue figures do not include retailers' markups of drug costs, so they are more properly characterized as retailer purchase costs rather than spending.)
Spending at clinics and non-federal hospitals, the other two large channel categories, increased slightly, with clinics ($36.2B in 2010) representing 11.8% of drug spend, up from 11.6% the year before, while hospitals ($28.0B) came in at 9.1%, down from 9.2% the year before.
Dispensing trends
There were 3.995.2 billion prescriptions filled in 2010, according to the IMS Institute, up 1.2% from 2009. Chains increased their share of this statistic as well, representing 54.4% of dispensing locations, while independents dropped from 19.1% in 2009 to 18.7%. Meanwhile, mail service was unchanged, at 6.6% for both 2009 and 2010. Even so, those statistics show that while chains fill more than half of prescriptions to garner a third of the spending, mail service fills one out of 15 prescriptions but garners one out of six drug-spend dollars. At independents, the proportional ratio between prescriptions filled and revenue generated is almost one-for-one.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.